Nabla Bio
We use AI to design antibodies for intractable diseases
Company facts
- Founded
- 2021
- Employees
- 8
- Headquarters
- United States
About
Our mission is to enable pharmaceutical and biotech companies to bring more antibody therapies to patients. Using AI and massively parallel experimentation, we design antibodies that precisely bind the disease target at the right location, while minimizing manufacturability and toxicity risks. We are a well-funded, revenue-generating, bilingual company of wet- and dry-lab scientists, and are founded by AI and protein design experts from Harvard University.
Open positions

AI Platform Engineer
The Role We’re hiring a senior engineer to build core infrastructure and tools that connect our AI models to real-world use. You’ll work across the full stack — front-end, back-end, and ML infrastructure — to build…

AI Scientist
The Role We’re hiring an exceptional AI Scientist to lead development of our core biomolecular modeling technologies. You’ll be responsible for building and improving the foundation models that power Nabla’s…